Full Transcript Why Antiparasitic Drugs Are Used in Cancer Care 0:02 It doesn't matter how good of a drug, 0:02 It doesn't matter how good of a drug, either repurposed or on-label is for 0:05 either repurposed or on-label is for 0:05 either repurposed or on-label is for cancer, if you are allergic to it, you 0:07 cancer, if you are allergic to it, you 0:07 cancer, if you are allergic to it, you should not be taking it or be given it, 0:09 should not be taking it or be given it, 0:09 should not be taking it or be given it, or if you're sensitive to it, because 0:11 or if you're sensitive to it, because 0:11 or if you're sensitive to it, because obviously that's going to have a very 0:12 obviously that's going to have a very 0:12 obviously that's going to have a very bad outcome that you just don't need. 0:19 I'm Dr. A. I use this channel to answer 0:19 I'm Dr. A. I use this channel to answer questions that we get and questions I 0:21 questions that we get and questions I 0:21 questions that we get and questions I get from patients and family and people 0:24 get from patients and family and people 0:24 get from patients and family and people all over the internet. I've been 0:25 all over the internet. I've been 0:25 all over the internet. I've been researching and teaching in the 0:27 researching and teaching in the 0:27 researching and teaching in the integrative and naturopathic medical 0:28 integrative and naturopathic medical 0:28 integrative and naturopathic medical communities for over 30 years and I've 0:31 communities for over 30 years and I've 0:31 communities for over 30 years and I've been in practice a long time and I get 0:33 been in practice a long time and I get 0:33 been in practice a long time and I get asked lots of questions. So, today I 0:35 asked lots of questions. So, today I 0:35 asked lots of questions. So, today I want to get into a question we got and 0:37 want to get into a question we got and 0:37 want to get into a question we got and this is going to be big picture and 0:39 this is going to be big picture and 0:39 this is going to be big picture and we'll get into other things that are a 0:41 we'll get into other things that are a 0:41 we'll get into other things that are a little more specific in other videos, 0:43 little more specific in other videos, 0:43 little more specific in other videos, but I get a lot of questions about 0:45 but I get a lot of questions about 0:45 but I get a lot of questions about repurposed drugs for cancer because I 0:48 repurposed drugs for cancer because I 0:48 repurposed drugs for cancer because I teach about that. Part of my practice is 0:50 teach about that. Part of my practice is 0:50 teach about that. Part of my practice is integrative oncology, so we use these 0:53 integrative oncology, so we use these 0:53 integrative oncology, so we use these things and we monitor them and all that. 0:55 things and we monitor them and all that. 0:55 things and we monitor them and all that. So, the questions, of course, are very 0:56 So, the questions, of course, are very 0:56 So, the questions, of course, are very common. The first thing I want to get
What Off Label and Repurposed Drugs Actually Mean 0:58 common. The first thing I want to get 0:58 common. The first thing I want to get into is repurposed or off-label drugs in 1:02 into is repurposed or off-label drugs in 1:02 into is repurposed or off-label drugs in cancer therapies include lots of 1:04 cancer therapies include lots of 1:04 cancer therapies include lots of different types of drugs. The one I want 1:06 different types of drugs. The one I want 1:06 different types of drugs. The one I want to talk about here shortly is 1:09 to talk about here shortly is 1:09 to talk about here shortly is anti-parasite drugs that are also used 1:12 anti-parasite drugs that are also used 1:12 anti-parasite drugs that are also used as repurposed or off-label drugs in 1:16 as repurposed or off-label drugs in 1:16 as repurposed or off-label drugs in cancer therapy. So, the first thing is 1:19 cancer therapy. So, the first thing is 1:19 cancer therapy. So, the first thing is why would we use something, quote, 1:21 why would we use something, quote, 1:21 why would we use something, quote, off-label or repurposed, the sort of new 1:25 off-label or repurposed, the sort of new 1:25 off-label or repurposed, the sort of new modern euphemism for off-label use of 1:27 modern euphemism for off-label use of 1:27 modern euphemism for off-label use of drugs? Well, currently in the United 1:29 drugs? Well, currently in the United 1:29 drugs? Well, currently in the United States, for the most part, any drug 1:31 States, for the most part, any drug 1:31 States, for the most part, any drug that's approved for one thing can be 1:34 that's approved for one thing can be 1:34 that's approved for one thing can be used for an off-label purpose if the 1:38 used for an off-label purpose if the 1:38 used for an off-label purpose if the physician clinician decides that that is 1:40 physician clinician decides that that is 1:40 physician clinician decides that that is medically indicated. So, you can have a 1:43 medically indicated. So, you can have a 1:43 medically indicated. So, you can have a drug that's approved for one particular 1:46 drug that's approved for one particular 1:46 drug that's approved for one particular thing in medicine and it might be wind 1:48 thing in medicine and it might be wind 1:48 thing in medicine and it might be wind up being used for a whole bunch of other 1:50 up being used for a whole bunch of other 1:50 up being used for a whole bunch of other things and that's the normal course of 1:52 things and that's the normal course of 1:52 things and that's the normal course of pharmacology and medicine. So, in 1:54 pharmacology and medicine. So, in 1:54 pharmacology and medicine. So, in repurposing drugs, it's another way of 1:57 repurposing drugs, it's another way of 1:57 repurposing drugs, it's another way of saying using it off-label because most 1:59 saying using it off-label because most 1:59 saying using it off-label because most of these drugs are not labeled for 2:02 of these drugs are not labeled for 2:02 of these drugs are not labeled for cancer treatment, generally speaking. 2:04 cancer treatment, generally speaking. 2:04 cancer treatment, generally speaking. Because there's lots of categories of 2:06 Because there's lots of categories of 2:06 Because there's lots of categories of repurposed drugs, for instance, some 2:09 repurposed drugs, for instance, some 2:09 repurposed drugs, for instance, some blood pressure medicines are repurposed 2:10 blood pressure medicines are repurposed 2:10 blood pressure medicines are repurposed cancer drugs, some blood cholesterol 2:13 cancer drugs, some blood cholesterol 2:13 cancer drugs, some blood cholesterol medicines are repurposed cancer drugs, 2:15 medicines are repurposed cancer drugs, 2:15 medicines are repurposed cancer drugs, some anti-inflammatory drugs are cancer 2:17 some anti-inflammatory drugs are cancer 2:17 some anti-inflammatory drugs are cancer repurposed drugs, etc. I just wanted to 2:20 repurposed drugs, etc. I just wanted to 2:20 repurposed drugs, etc. I just wanted to bring up the anti-parasite category of 2:22 bring up the anti-parasite category of 2:23 bring up the anti-parasite category of drugs, which is heavily represented in 2:25 drugs, which is heavily represented in 2:25 drugs, which is heavily represented in the off-label or repurposed cancer drug 2:28 the off-label or repurposed cancer drug 2:28 the off-label or repurposed cancer drug treatment protocol world. So, the first 2:30 treatment protocol world. So, the first 2:30 treatment protocol world. So, the first thing is, why in the world would a
How Antiparasitic Drugs Affect the Immune System 2:34 thing is, why in the world would a 2:34 thing is, why in the world would a anti-parasite drug, number one, be 2:36 anti-parasite drug, number one, be 2:36 anti-parasite drug, number one, be thought of to be used in the world of 2:38 thought of to be used in the world of 2:38 thought of to be used in the world of cancer, but also why might it work, what 2:41 cancer, but also why might it work, what 2:41 cancer, but also why might it work, what would it help, etc. So, the first thing 2:44 would it help, etc. So, the first thing 2:44 would it help, etc. So, the first thing is that it's not uncommon to see 2:47 is that it's not uncommon to see 2:47 is that it's not uncommon to see anti-infective drugs used alongside 2:50 anti-infective drugs used alongside 2:50 anti-infective drugs used alongside other cancer treatments for the general 2:52 other cancer treatments for the general 2:52 other cancer treatments for the general reason that some cancer treatments might 2:55 reason that some cancer treatments might 2:55 reason that some cancer treatments might help you be more open to infections, so 2:58 help you be more open to infections, so 2:58 help you be more open to infections, so we have to give you anti-infective drugs 3:00 we have to give you anti-infective drugs 3:00 we have to give you anti-infective drugs to counter that. So, that's sort of the 3:01 to counter that. So, that's sort of the 3:02 to counter that. So, that's sort of the obvious reason, right? A little bit 3:03 obvious reason, right? A little bit 3:03 obvious reason, right? A little bit though more below the surface is most 3:06 though more below the surface is most 3:06 though more below the surface is most drugs that are anti-something, so like 3:09 drugs that are anti-something, so like 3:09 drugs that are anti-something, so like an anti-fungal, antiviral, antibiotic 3:12 an anti-fungal, antiviral, antibiotic 3:13 an anti-fungal, antiviral, antibiotic {slash} antibacterial, anti-parasite, 3:16 {slash} antibacterial, anti-parasite, 3:16 {slash} antibacterial, anti-parasite, all of these actually are used in the 3:18 all of these actually are used in the 3:18 all of these actually are used in the repurposed drug world for cancer, for 3:21 repurposed drug world for cancer, for 3:21 repurposed drug world for cancer, for not the infectious part. So, what do 3:23 not the infectious part. So, what do 3:23 not the infectious part. So, what do they do beyond being anti-infective? 3:26 they do beyond being anti-infective? 3:26 they do beyond being anti-infective? Like, why do I see this drug that should 3:28 Like, why do I see this drug that should 3:28 Like, why do I see this drug that should kill parasites being given to my cousin 3:31 kill parasites being given to my cousin 3:31 kill parasites being given to my cousin for cancer? Well, most of the 3:33 for cancer? Well, most of the 3:33 for cancer? Well, most of the anti-drugs, whether it's antibiotic, 3:36 anti-drugs, whether it's antibiotic, 3:36 anti-drugs, whether it's antibiotic, antiviral, antifungal, antiparasite, 3:38 antiviral, antifungal, antiparasite, 3:38 antiviral, antifungal, antiparasite, etc., have other immune functions that 3:40 etc., have other immune functions that 3:40 etc., have other immune functions that they do. They're just not popularized, 3:42 they do. They're just not popularized, 3:42 they do. They're just not popularized, not talked about a lot till recently. 3:44 not talked about a lot till recently. 3:44 not talked about a lot till recently. Anti-parasite drug category, of which 3:47 Anti-parasite drug category, of which 3:47 Anti-parasite drug category, of which there's many subtypes and all that, are 3:49 there's many subtypes and all that, are 3:49 there's many subtypes and all that, are used primarily as immunomodulators. 3:53 used primarily as immunomodulators. 3:53 used primarily as immunomodulators. So, you might then say, "Well, why would 3:54 So, you might then say, "Well, why would 3:54 So, you might then say, "Well, why would immunomodulation help cancer?" Part of 3:57 immunomodulation help cancer?" Part of 3:57 immunomodulation help cancer?" Part of what drives cancer forward is the immune 4:01 what drives cancer forward is the immune 4:01 what drives cancer forward is the immune system getting off balance and the 4:05 system getting off balance and the 4:05 system getting off balance and the cancer cells and the cancer 4:07 cancer cells and the cancer 4:07 cancer cells and the cancer microenvironment, 4:08 microenvironment, 4:08 microenvironment, the area that keeps the cancer cells 4:10 the area that keeps the cancer cells 4:10 the area that keeps the cancer cells working, and then the immune crosstalk 4:13 working, and then the immune crosstalk 4:13 working, and then the immune crosstalk between normal cells and cancer cells, 4:15 between normal cells and cancer cells, 4:16 between normal cells and cancer cells, that all gets kind of skewed into a 4:18 that all gets kind of skewed into a 4:18 that all gets kind of skewed into a pro-cancer immune modulation that's not 4:21 pro-cancer immune modulation that's not 4:21 pro-cancer immune modulation that's not good for you. So, things like 4:24 good for you. So, things like 4:24 good for you. So, things like antiparasitic drugs are sometimes given 4:27 antiparasitic drugs are sometimes given 4:27 antiparasitic drugs are sometimes given to help push back against that negative 4:30 to help push back against that negative 4:30 to help push back against that negative immune modulation, the bad for you 4:32 immune modulation, the bad for you 4:32 immune modulation, the bad for you immune modulation, to help you have more 4:35 immune modulation, to help you have more 4:35 immune modulation, to help you have more balance and calm down that pro-cancer 4:38 balance and calm down that pro-cancer 4:38 balance and calm down that pro-cancer drive. 4:39 drive. 4:39 drive. >> Quick plug here, if you're a healthcare 4:40 >> Quick plug here, if you're a healthcare 4:40 >> Quick plug here, if you're a healthcare practitioner working with patients with 4:42 practitioner working with patients with 4:42 practitioner working with patients with these issues, I have a CE website and I 4:45 these issues, I have a CE website and I 4:45 these issues, I have a CE website and I do webinars on this topic and others. 4:48 do webinars on this topic and others. 4:48 do webinars on this topic and others. So, we're going to put a link in the 4:50 So, we're going to put a link in the 4:50 So, we're going to put a link in the description below to the CE website link 4:53 description below to the CE website link 4:53 description below to the CE website link and the particular webinar of interest. 4:55 and the particular webinar of interest. 4:55 and the particular webinar of interest. Thank you. 4:55 Thank you. 4:55 Thank you. >> So, sometimes what you see on, you know,
Do Parasites Actually Cause Cancer 4:58 >> So, sometimes what you see on, you know, 4:58 >> So, sometimes what you see on, you know, social media a lot or whatever is 5:00 social media a lot or whatever is 5:00 social media a lot or whatever is somebody will assume, "Well, because 5:02 somebody will assume, "Well, because 5:02 somebody will assume, "Well, because it's a antibacterial drug or 5:04 it's a antibacterial drug or 5:04 it's a antibacterial drug or antiparasitic drug in case we're talking 5:06 antiparasitic drug in case we're talking 5:06 antiparasitic drug in case we're talking about right now, then does that mean 5:08 about right now, then does that mean 5:08 about right now, then does that mean that the parasites that that drug kills 5:10 that the parasites that that drug kills 5:11 that the parasites that that drug kills are what caused my cancer?" And that's 5:13 are what caused my cancer?" And that's 5:13 are what caused my cancer?" And that's usually not the case. I know people 5:15 usually not the case. I know people 5:15 usually not the case. I know people disagree with that, but there are 5:17 disagree with that, but there are 5:17 disagree with that, but there are associations with lots of infections and 5:19 associations with lots of infections and 5:19 associations with lots of infections and cancer. That's not a debatable fact, 5:21 cancer. That's not a debatable fact, 5:21 cancer. That's not a debatable fact, it's very common. And in more advanced 5:23 it's very common. And in more advanced 5:23 it's very common. And in more advanced cancers, you see lots of other 5:25 cancers, you see lots of other 5:25 cancers, you see lots of other infections that are, you know, around 5:27 infections that are, you know, around 5:27 infections that are, you know, around and are doing what? Infections also 5:30 and are doing what? Infections also 5:30 and are doing what? Infections also throw off your immune system and it 5:32 throw off your immune system and it 5:32 throw off your immune system and it turns out that chronic infectious things 5:34 turns out that chronic infectious things 5:34 turns out that chronic infectious things can push you into the immune imbalance 5:37 can push you into the immune imbalance 5:37 can push you into the immune imbalance that is pro-cancer. So, it's not 5:39 that is pro-cancer. So, it's not 5:39 that is pro-cancer. So, it's not necessarily that the infections created 5:42 necessarily that the infections created 5:42 necessarily that the infections created a chicken-and-egg sort of thing. The 5:44 a chicken-and-egg sort of thing. The 5:44 a chicken-and-egg sort of thing. The antiparasitic and the other anti-drugs 5:46 antiparasitic and the other anti-drugs 5:46 antiparasitic and the other anti-drugs are given as immunomodulators to oppose 5:49 are given as immunomodulators to oppose 5:49 are given as immunomodulators to oppose what is pro-cancer in the immune 5:52 what is pro-cancer in the immune 5:52 what is pro-cancer in the immune imbalance that's going on. Now, because 5:54 imbalance that's going on. Now, because 5:54 imbalance that's going on. Now, because things are popularized, you know, now 5:57 things are popularized, you know, now 5:57 things are popularized, you know, now especially we have the internet, things 5:58 especially we have the internet, things 5:58 especially we have the internet, things go around the world in milliseconds, and 6:01 go around the world in milliseconds, and 6:01 go around the world in milliseconds, and something that gets popularized and goes 6:04 something that gets popularized and goes 6:04 something that gets popularized and goes around is, well, there's, you know, this 6:06 around is, well, there's, you know, this 6:06 around is, well, there's, you know, this one off-label or repurposed drug is good 6:08 one off-label or repurposed drug is good 6:08 one off-label or repurposed drug is good for cancer. Well, it might be, but what 6:11 for cancer. Well, it might be, but what 6:11 for cancer. Well, it might be, but what we find in clinical practices is because 6:13 we find in clinical practices is because 6:13 we find in clinical practices is because we're trying to rebalance immune 6:15 we're trying to rebalance immune 6:15 we're trying to rebalance immune function and inhibit the signaling 6:17 function and inhibit the signaling 6:17 function and inhibit the signaling things that go on that trigger a 6:20 things that go on that trigger a 6:20 things that go on that trigger a pro-cancer environment, usually that is 6:23 pro-cancer environment, usually that is 6:23 pro-cancer environment, usually that is not done with one drug driving the whole 6:26 not done with one drug driving the whole 6:26 not done with one drug driving the whole bus, as it were. So, a lot of times 6:28 bus, as it were. So, a lot of times 6:28 bus, as it were. So, a lot of times you'll see a particular drug, whether 6:31 you'll see a particular drug, whether 6:31 you'll see a particular drug, whether it's something like mebendazole or its 6:34 it's something like mebendazole or its 6:34 it's something like mebendazole or its cousin albendazole or fenbendazole, 6:37 cousin albendazole or fenbendazole, 6:37 cousin albendazole or fenbendazole, those guys, or ivermectin, or any of the 6:39 those guys, or ivermectin, or any of the 6:39 those guys, or ivermectin, or any of the other drugs, chloroquine family, all of 6:42 other drugs, chloroquine family, all of 6:42 other drugs, chloroquine family, all of that stuff, you'll see one of them kind 6:44 that stuff, you'll see one of them kind 6:44 that stuff, you'll see one of them kind of get lost spotlight in the repurposed 6:46 of get lost spotlight in the repurposed 6:46 of get lost spotlight in the repurposed oncology community, and you know, they
Why Combining Repurposed Drugs Works Better 6:48 oncology community, and you know, they 6:48 oncology community, and you know, they do work in that world. What we find 6:50 do work in that world. What we find 6:50 do work in that world. What we find clinically usually, and there's emerging 6:53 clinically usually, and there's emerging 6:53 clinically usually, and there's emerging research on this, and usually this goes 6:55 research on this, and usually this goes 6:55 research on this, and usually this goes along with the emerging research, is if 6:57 along with the emerging research, is if 6:57 along with the emerging research, is if you use a balance of repurposed 7:01 you use a balance of repurposed 7:01 you use a balance of repurposed medications and then other things that 7:03 medications and then other things that 7:03 medications and then other things that we do, you get more immunomodulation 7:05 we do, you get more immunomodulation 7:05 we do, you get more immunomodulation towards the anti-cancer side of the 7:07 towards the anti-cancer side of the 7:07 towards the anti-cancer side of the ledger. So, while one particular type of 7:10 ledger. So, while one particular type of 7:10 ledger. So, while one particular type of drug may be a category like the 7:11 drug may be a category like the 7:11 drug may be a category like the benzimidazoles I mentioned or 7:13 benzimidazoles I mentioned or 7:13 benzimidazoles I mentioned or ivermectin, which is an avermectin drug 7:16 ivermectin, which is an avermectin drug 7:16 ivermectin, which is an avermectin drug or others, they all might have a role to 7:18 or others, they all might have a role to 7:18 or others, they all might have a role to play. We might rotate them, we might use 7:20 play. We might rotate them, we might use 7:20 play. We might rotate them, we might use them together in some sort of sequence, 7:23 them together in some sort of sequence, 7:23 them together in some sort of sequence, so that each one does its own special 7:25 so that each one does its own special 7:25 so that each one does its own special thing and helps be anti-cancer. The 7:28 thing and helps be anti-cancer. The 7:28 thing and helps be anti-cancer. The other thing that that allows clinically 7:31 other thing that that allows clinically 7:31 other thing that that allows clinically is for you, in using a repurposed drug, 7:34 is for you, in using a repurposed drug, 7:34 is for you, in using a repurposed drug, to not try and do all the work with one 7:36 to not try and do all the work with one 7:37 to not try and do all the work with one drug. It allows you to lower the dose of 7:39 drug. It allows you to lower the dose of 7:39 drug. It allows you to lower the dose of each of the drugs and use them as sort 7:42 each of the drugs and use them as sort 7:42 each of the drugs and use them as sort of a little symphony of 7:43 of a little symphony of 7:43 of a little symphony of immunomodulators. That makes the dosing 7:46 immunomodulators. That makes the dosing 7:46 immunomodulators. That makes the dosing more safe for your body and it makes the 7:48 more safe for your body and it makes the 7:48 more safe for your body and it makes the side effect profile lower. So, what are 7:50 side effect profile lower. So, what are 7:50 side effect profile lower. So, what are the cautions that we have to be careful
Side Effects and Cautions to Monitor 7:52 the cautions that we have to be careful 7:52 the cautions that we have to be careful around repurposed drugs, et cetera? 7:54 around repurposed drugs, et cetera? 7:54 around repurposed drugs, et cetera? Well, any drug that you use, if you're 7:56 Well, any drug that you use, if you're 7:56 Well, any drug that you use, if you're on chemotherapy, there's plenty of 7:57 on chemotherapy, there's plenty of 7:58 on chemotherapy, there's plenty of cautions. If you're on an antibiotic, 7:59 cautions. If you're on an antibiotic, 7:59 cautions. If you're on an antibiotic, there's plenty of cautions, et cetera. 8:01 there's plenty of cautions, et cetera. 8:01 there's plenty of cautions, et cetera. But, the biggest cautions are number 8:02 But, the biggest cautions are number 8:02 But, the biggest cautions are number one, what does that drug normally do and 8:05 one, what does that drug normally do and 8:05 one, what does that drug normally do and what are its usual side effects? So, if 8:06 what are its usual side effects? So, if 8:06 what are its usual side effects? So, if I give you a repurposed cancer drug 8:08 I give you a repurposed cancer drug 8:08 I give you a repurposed cancer drug that's a blood pressure drug, there are 8:10 that's a blood pressure drug, there are 8:10 that's a blood pressure drug, there are those. What am I concerned about? I 8:11 those. What am I concerned about? I 8:11 those. What am I concerned about? I might be concerned that your blood 8:13 might be concerned that your blood 8:13 might be concerned that your blood pressure might go too low. That can be 8:15 pressure might go too low. That can be 8:15 pressure might go too low. That can be very bad for you. So, let's monitor 8:16 very bad for you. So, let's monitor 8:16 very bad for you. So, let's monitor that, watch the dose. What if I give you 8:18 that, watch the dose. What if I give you 8:18 that, watch the dose. What if I give you an antibiotic or an antiparasitic drug 8:20 an antibiotic or an antiparasitic drug 8:20 an antibiotic or an antiparasitic drug like we're talking about here? Well, we 8:21 like we're talking about here? Well, we 8:21 like we're talking about here? Well, we have to consider that you may already 8:24 have to consider that you may already 8:24 have to consider that you may already have parasites in your body or bacteria, 8:26 have parasites in your body or bacteria, 8:26 have parasites in your body or bacteria, something that are going to die and that 8:28 something that are going to die and that 8:28 something that are going to die and that might give you side effects. It might be 8:30 might give you side effects. It might be 8:30 might give you side effects. It might be digestive side effects, might be pain, 8:32 digestive side effects, might be pain, 8:32 digestive side effects, might be pain, inflammation, whatever else. So, we just 8:34 inflammation, whatever else. So, we just 8:34 inflammation, whatever else. So, we just have to look at what does that drug do 8:36 have to look at what does that drug do 8:36 have to look at what does that drug do not in cancer when we use it and just 8:38 not in cancer when we use it and just 8:38 not in cancer when we use it and just monitor for the side effects. Normally, 8:40 monitor for the side effects. Normally, 8:40 monitor for the side effects. Normally, because of this kind of symphony collage 8:43 because of this kind of symphony collage 8:43 because of this kind of symphony collage effect of using multiple drugs at lower 8:45 effect of using multiple drugs at lower 8:45 effect of using multiple drugs at lower doses, we don't get as many of these 8:47 doses, we don't get as many of these 8:47 doses, we don't get as many of these side effects, but they certainly have to 8:48 side effects, but they certainly have to 8:48 side effects, but they certainly have to be monitored. The other thing is, it 8:50 be monitored. The other thing is, it 8:50 be monitored. The other thing is, it doesn't matter how good of a drug,
Allergies and Sensitivities to Watch For 8:52 doesn't matter how good of a drug, 8:52 doesn't matter how good of a drug, either repurposed or on label is for 8:55 either repurposed or on label is for 8:55 either repurposed or on label is for cancer, if you are allergic to it, you 8:58 cancer, if you are allergic to it, you 8:58 cancer, if you are allergic to it, you should not be taking it or be given it 9:00 should not be taking it or be given it 9:00 should not be taking it or be given it or if you're sensitive to it because 9:01 or if you're sensitive to it because 9:01 or if you're sensitive to it because obviously that's going to have a very 9:03 obviously that's going to have a very 9:03 obviously that's going to have a very bad outcome that you just don't need. 9:05 bad outcome that you just don't need. 9:05 bad outcome that you just don't need. Well, I hope this quick little entree 9:07 Well, I hope this quick little entree 9:07 Well, I hope this quick little entree into antiparasitic drugs repurposed for 9:09 into antiparasitic drugs repurposed for 9:09 into antiparasitic drugs repurposed for cancer helps being that they are in the 9:11 cancer helps being that they are in the 9:12 cancer helps being that they are in the immunomodulatory class. We usually use 9:14 immunomodulatory class. We usually use 9:14 immunomodulatory class. We usually use them together with other drugs and 9:16 them together with other drugs and 9:16 them together with other drugs and usually less of each one does more of 9:19 usually less of each one does more of 9:19 usually less of each one does more of the job overall. I think this is an area 9:21 the job overall. I think this is an area 9:21 the job overall. I think this is an area as we move forward in the coming years 9:23 as we move forward in the coming years 9:23 as we move forward in the coming years and decades where there's going to be a 9:25 and decades where there's going to be a 9:25 and decades where there's going to be a growth area for anti-cancer treatments, 9:28 growth area for anti-cancer treatments, 9:28 growth area for anti-cancer treatments, for cancer remission treatments, et 9:30 for cancer remission treatments, et 9:30 for cancer remission treatments, et cetera. Obviously, we're going to do 9:31 cetera. Obviously, we're going to do 9:31 cetera. Obviously, we're going to do more content on this, but I really want 9:33 more content on this, but I really want 9:33 more content on this, but I really want to get this one out because it's just 9:35 to get this one out because it's just 9:35 to get this one out because it's just such a common question that we get. All 9:37 such a common question that we get. All 9:37 such a common question that we get. All right, I'm Dr. A. Thank you for tuning 9:39 right, I'm Dr. A. Thank you for tuning 9:39 right, I'm Dr. A. Thank you for tuning in. Thanks for all of you who have 9:40 in. Thanks for all of you who have 9:41 in. Thanks for all of you who have subscribed. Please do notifications, 9:43 subscribed. Please do notifications, 9:43 subscribed. Please do notifications, like, share, subscribe if you haven't. 9:45 like, share, subscribe if you haven't. 9:45 like, share, subscribe if you haven't. I'll see you all in the next video.
Comments